CRISIL Research has assigned a CRISIL IER fundamental grade of ‘3/5’ to Omkar Speciality Chemicals. The grade indicates that the company’s fundamentals are ‘good’ relative to other listed equity securities in India. The rating agency has also assigned a valuation grade of ‘5/5’ to the company.
The fundamental grade factors in the company’s established position in pharma intermediates and the specialty chemicals industry. The company derives 70% of its revenues from pharma intermediates and the balance from specialty chemicals.
Omkar Speciality manufactures pharmaceutical intermediaries and specialty chemicals. The company has a diverse portfolio of over 80 products, both organic and inorganic compounds. These compounds are used in a wide range of industries like pharmaceutical, glass, agrochemicals, poultry, paints and dyes, electroplating, textiles, cosmetics and ceramic. The company has three manufacturing units in Thane district, Maharashtra and plans to set up a fourth one in the same area.